viernes, 31 de diciembre de 2021

Remember Ebola: stop mass COVID deaths in Africa

Remember Ebola: stop mass COVID deaths in Africa

New Data Support a Causal Role for Depression in Alzheimer's

New Data Support a Causal Role for Depression in Alzheimer's

COVID Vaccines Rarely Lead to Serious Problems in Ages 5-11: CDC

COVID Vaccines Rarely Lead to Serious Problems in Ages 5-11: CDC

Post-traumatic Epilepsy Common Even After 'Mild' TBI

Post-traumatic Epilepsy Common Even After 'Mild' TBI

HIV/AIDS Treatment Guidelines | NIH

HIV/AIDS Treatment Guidelines | NIH

What's New in the Guidelines | NIH

What's New in the Guidelines | NIH

COVID-19: Omicron may be more likely to cause re-infection

COVID-19: Omicron may be more likely to cause re-infection

Hospitalisation and ICU admission in children with COVID-19

Hospitalisation and ICU admission in children with COVID-19

COVID-19: mRNA vaccine after natural infection

COVID-19: mRNA vaccine after natural infection

New COVID-19 vaccination adverse events in rheumatic diseases

New COVID-19 vaccination adverse events in rheumatic diseases

ASH 2021 — Thrombosis in Covid-19 has a different proteomic profile

ASH 2021 — Thrombosis in Covid-19 has a different proteomic profile

Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults | FDA

Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults | FDA

Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19 | FDA

Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19 | FDA

Frequently Asked Questions on the Emergency Use Authorization for Molnupiravir for Treatment of COVID-19

Frequently Asked Questions on the Emergency Use Authorization for Molnupiravir for Treatment of COVID-19

Frequently Asked Questions on the Emergency Use Authorization for Paxlovid for Treatment of COVID-19

Frequently Asked Questions on the Emergency Use Authorization for Paxlovid for Treatment of COVID-19

New Links on MedlinePlus

New Links on MedlinePlus

CDC cuts recommended isolation period for Americans to 5 days; can India follow suit? | Lifestyle News,The Indian Express

CDC cuts recommended isolation period for Americans to 5 days; can India follow suit? | Lifestyle News,The Indian Express

Covid-19: Your complete guide to caring for someone at home | Lifestyle News,The Indian Express

Covid-19: Your complete guide to caring for someone at home | Lifestyle News,The Indian Express

No travel history, just scratchy throat: Should you get tested for the Omicron variant? | Lifestyle News,The Indian Express

No travel history, just scratchy throat: Should you get tested for the Omicron variant? | Lifestyle News,The Indian Express

Things to do for a healthy heart during winter | Lifestyle News,The Indian Express

Things to do for a healthy heart during winter | Lifestyle News,The Indian Express

When should you go to hospital for a headache? A doctor explains how to tell if it’s an emergency | Lifestyle News,The Indian Express

When should you go to hospital for a headache? A doctor explains how to tell if it’s an emergency | Lifestyle News,The Indian Express

jueves, 30 de diciembre de 2021

CDC Updates and Shortens Recommended Isolation and Quarantine Period for General Population | CDC Online Newsroom | CDC

CDC Updates and Shortens Recommended Isolation and Quarantine Period for General Population | CDC Online Newsroom | CDC

Warning signs and symptoms of heart disease: MedlinePlus Medical Encyclopedia

Warning signs and symptoms of heart disease: MedlinePlus Medical Encyclopedia

Scientists discover the mechanism that causes nerve destruction in ALS - ISRAEL21c

Scientists discover the mechanism that causes nerve destruction in ALS - ISRAEL21c

HR survey confirms Covid-caused ‘Great Resignation’ - ISRAEL21c

HR survey confirms Covid-caused ‘Great Resignation’ - ISRAEL21c

Israel begins world-first trial of 4th Covid vaccine dose - ISRAEL21c

Israel begins world-first trial of 4th Covid vaccine dose - ISRAEL21c

Covid pandemic may be nearing end, experts suggest - ISRAEL21c

Covid pandemic may be nearing end, experts suggest - ISRAEL21c

Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults | FDA

Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults | FDA

Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19 | FDA

Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19 | FDA

COVID-19, Sure, but What Else Will We Remember 2021 For?

COVID-19, Sure, but What Else Will We Remember 2021 For?

Prostatectomy Without Biopsy Is Feasible, Says German Study

Prostatectomy Without Biopsy Is Feasible, Says German Study

FDA approves long-acting injectable cabotegravir: first injectable HIV prevention treatment

FDA approves long-acting injectable cabotegravir: first injectable HIV prevention treatment

AML in remission: tipifarnib maintenance therapy fails to confer survival benefit

AML in remission: tipifarnib maintenance therapy fails to confer survival benefit

Healthy lifestyle linked to lower risk for breast cancer

Healthy lifestyle linked to lower risk for breast cancer

This virus expert accurately predicted 800,000 Americans would die of COVID. What does he think the future holds? - Genetic Literacy Project

This virus expert accurately predicted 800,000 Americans would die of COVID. What does he think the future holds? - Genetic Literacy Project

Bothersome Genitourinary Symptoms After Breast Cancer

Bothersome Genitourinary Symptoms After Breast Cancer

Clinical Trials Update from NCI, December 2021

Clinical Trials Update from NCI, December 2021

New Links on MedlinePlus

New Links on MedlinePlus

In Vitro Diagnostics EUAs - Antigen Diagnostic Tests for SARS-CoV-2 | FDA

In Vitro Diagnostics EUAs - Antigen Diagnostic Tests for SARS-CoV-2 | FDA

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

New on NCI’s Websites for December 2021 - National Cancer Institute

New on NCI’s Websites for December 2021 - National Cancer Institute

miércoles, 29 de diciembre de 2021

Journal of Experimental & Clinical Cancer Research | Home page

Journal of Experimental & Clinical Cancer Research | Home page

Breast Cancer Research | Home page

Breast Cancer Research | Home page

BMC Cancer | Home page

BMC Cancer | Home page

Biology of Sex Differences | Home page

Biology of Sex Differences | Home page

Orphanet Journal of Rare Diseases | Home page

Orphanet Journal of Rare Diseases | Home page

Illness From Breakthrough COVID Often Severe for Cancer Patients

Illness From Breakthrough COVID Often Severe for Cancer Patients

Coronavirus Can Spread to Heart, Brain Days After Infection

Coronavirus Can Spread to Heart, Brain Days After Infection

Corrected: December 2021 CC News

Corrected: December 2021 CC News

News & Events - National Cancer Institute

News & Events - National Cancer Institute

Vascular Dementia: Causes, Symptoms, and Treatments | National Institute on Aging

Vascular Dementia: Causes, Symptoms, and Treatments | National Institute on Aging

Depression and Complementary Health Approaches | NCCIH

Depression and Complementary Health Approaches | NCCIH

Primary CNS Lymphoma Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Primary CNS Lymphoma Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Ovarian Low Malignant Potential Tumors Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Ovarian Low Malignant Potential Tumors Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Levels of Evidence for Cancer Screening and Prevention Studies (PDQ®)–Health Professional Version - National Cancer Institute

Levels of Evidence for Cancer Screening and Prevention Studies (PDQ®)–Health Professional Version - National Cancer Institute

Childhood Extracranial Germ Cell Tumors Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Childhood Extracranial Germ Cell Tumors Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Childhood Craniopharyngioma Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Childhood Craniopharyngioma Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version - National Cancer Institute

martes, 28 de diciembre de 2021

Data shows racial disparities in Alzheimer’s disease diagnosis between Black and white research study participants | National Institute on Aging

Data shows racial disparities in Alzheimer’s disease diagnosis between Black and white research study participants | National Institute on Aging

Immune system may play harmful role in Lewy body dementia | National Institute on Aging

Immune system may play harmful role in Lewy body dementia | National Institute on Aging

Fasting blood glucose levels in mouse models might not translate to age-related metabolic changes in humans | National Institute on Aging

Fasting blood glucose levels in mouse models might not translate to age-related metabolic changes in humans | National Institute on Aging

Changes in a small area in the brainstem could help detect Alzheimer’s disease earlier | National Institute on Aging

Changes in a small area in the brainstem could help detect Alzheimer’s disease earlier | National Institute on Aging

Viagra associated with reduced risk of Alzheimer’s disease | National Institute on Aging

Viagra associated with reduced risk of Alzheimer’s disease | National Institute on Aging

Ritalin reduced apathy in NIA-funded Alzheimer’s clinical trial | National Institute on Aging

Ritalin reduced apathy in NIA-funded Alzheimer’s clinical trial | National Institute on Aging

Family member availability predicts likelihood of unpaid care for people living with dementia | National Institute on Aging

Family member availability predicts likelihood of unpaid care for people living with dementia | National Institute on Aging

Fauci: Omicron-specific version of Covid vaccines may not be necessary

Fauci: Omicron-specific version of Covid vaccines may not be necessary

Review uncovers weak COVID clinical practice guidelines | CIDRAP

Review uncovers weak COVID clinical practice guidelines | CIDRAP

Interim recommendations for heterologous COVID-19 vaccine schedules

Interim recommendations for heterologous COVID-19 vaccine schedules

CDC advisors recommend mRNA COVID vaccines over J&J | CIDRAP

CDC advisors recommend mRNA COVID vaccines over J&J | CIDRAP

An Omicron oddity: unlinking case rates and death rates - STAT

An Omicron oddity: unlinking case rates and death rates - STAT

How Long Does Omicron Take to Make You Sick? - The Atlantic

How Long Does Omicron Take to Make You Sick? - The Atlantic

During a COVID-19 surge, ‘crisis standards of care’ involve excruciating choices and impossible ethical decisions for hospital staff

During a COVID-19 surge, ‘crisis standards of care’ involve excruciating choices and impossible ethical decisions for hospital staff

More reports bolster evidence of lower Omicron severity | CIDRAP

More reports bolster evidence of lower Omicron severity | CIDRAP

Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research - The Lancet Respiratory Medicine

Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research - The Lancet Respiratory Medicine

Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older | Acute Coronary Syndromes | JAMA | JAMA Network

Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older | Acute Coronary Syndromes | JAMA | JAMA Network

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients | NEJM

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients | NEJM

Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis | Global Health | JAMA Network Open | JAMA Network

Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis | Global Health | JAMA Network Open | JAMA Network

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial - The Lancet

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial - The Lancet

Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show | The BMJ

Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show | The BMJ

lunes, 27 de diciembre de 2021

SARS-CoV-2 Alpha variant mutated to evade the immune system

SARS-CoV-2 Alpha variant mutated to evade the immune system

Uptake of COVID-19 vaccine doses increases before Christmas in England

Uptake of COVID-19 vaccine doses increases before Christmas in England

How can we increase confidence in the COVID-19 vaccine?

How can we increase confidence in the COVID-19 vaccine?

Interactive COVID-19 Map by Univadis

Interactive COVID-19 Map by Univadis

Long COVID Is Pitting Patients Against Doctors. That's a Problem.

Long COVID Is Pitting Patients Against Doctors. That's a Problem.

Remdesivir May Keep Unvaccinated Out of the Hospital: Study

Remdesivir May Keep Unvaccinated Out of the Hospital: Study

FDA Okays Emergency Use of Molnupiravir Pill for COVID-19

FDA Okays Emergency Use of Molnupiravir Pill for COVID-19

Anti-COVID Antibody Combo Receives Mixed Response

Anti-COVID Antibody Combo Receives Mixed Response

Mutation of NCOR2 Gene Likely Fuels Prostate Cancer Progression

Mutation of NCOR2 Gene Likely Fuels Prostate Cancer Progression

A high-fiber diet may improve the response of melanoma patients to immunotherapy | National Institutes of Health (NIH)

A high-fiber diet may improve the response of melanoma patients to immunotherapy | National Institutes of Health (NIH)

sábado, 25 de diciembre de 2021

Vitamin D counters bone density loss with aromatase inhibitors

Vitamin D counters bone density loss with aromatase inhibitors

Women struggle with benzodiazepine addiction post chemotherapy treatment

Women struggle with benzodiazepine addiction post chemotherapy treatment

Breast cancer-related musculoskeletal pain alleviated with acupuncture

Breast cancer-related musculoskeletal pain alleviated with acupuncture

Cancer risk tied to some manufactured foods

Cancer risk tied to some manufactured foods

Cardiovascular effects of breast cancer treatment vary based on weight, menopausal status

Cardiovascular effects of breast cancer treatment vary based on weight, menopausal status

SABCS 2021 Highlights & Complete Coverage | Univadis

SABCS 2021 Highlights & Complete Coverage | Univadis

COVID-19: post-COVID symptoms found in up to 8% of children, young people

COVID-19: post-COVID symptoms found in up to 8% of children, young people

COVID-19: Pfizer booster dose amidst delta variant may lower COVID-19 mortality by 90%

COVID-19: Pfizer booster dose amidst delta variant may lower COVID-19 mortality by 90%

COVID-19: delta variant, not waning immunity, tied to declines in vaccine effectiveness

COVID-19: delta variant, not waning immunity, tied to declines in vaccine effectiveness

COVID-19 Around the world weekly highlights: mandatory face mask, vaccination for children, and booster doses…

COVID-19 Around the world weekly highlights: mandatory face mask, vaccination for children, and booster doses…

Co-administration of influenza and COVID-19 vaccines

Co-administration of influenza and COVID-19 vaccines

Disarming a blood-clotting protein prevents gum disease in mice | National Institutes of Health (NIH)

Disarming a blood-clotting protein prevents gum disease in mice | National Institutes of Health (NIH)

Fiber boosts melanoma patients’ response to immunotherapy - National Cancer Institute

Fiber boosts melanoma patients’ response to immunotherapy - National Cancer Institute

Teeth Grinding | Back Pain | COVID-19 Vaccine Protection | Alcohol Terms | Teen Cancer Support

Teeth Grinding | Back Pain | COVID-19 Vaccine Protection | Alcohol Terms | Teen Cancer Support

jueves, 23 de diciembre de 2021

Omicron Variant: What You Need to Know | CDC

Omicron Variant: What You Need to Know | CDC

FDA Okays Emergency Use of Molnupiravir Pill for COVID-19

FDA Okays Emergency Use of Molnupiravir Pill for COVID-19

FDA Authorizes Pfizer Antiviral Pill for COVID-19

FDA Authorizes Pfizer Antiviral Pill for COVID-19

Novel Agents for Adult ALL: Is it Curtains for Chemo?

Novel Agents for Adult ALL: Is it Curtains for Chemo?

The Breast Cancer With No Target May Have One: NOS

The Breast Cancer With No Target May Have One: NOS

US authorizes Merck’s at-home antiviral COVID-19 pill | World News,The Indian Express

US authorizes Merck’s at-home antiviral COVID-19 pill | World News,The Indian Express

Explained: Omicron rising, but Delta still dominant | Explained News,The Indian Express

Explained: Omicron rising, but Delta still dominant | Explained News,The Indian Express

What are the symptoms of Omicron?

What are the symptoms of Omicron?

New Links on MedlinePlus

New Links on MedlinePlus

Eight substances added to 15th Report on Carcinogens | National Institutes of Health (NIH)

Eight substances added to 15th Report on Carcinogens | National Institutes of Health (NIH)

2021 Research Highlights — Basic Research Insights | National Institutes of Health (NIH)

2021 Research Highlights — Basic Research Insights | National Institutes of Health (NIH)

2021 Research Highlights — Promising Medical Findings | National Institutes of Health (NIH)

2021 Research Highlights — Promising Medical Findings | National Institutes of Health (NIH)

2021 Research Highlights — Human Health Advances | National Institutes of Health (NIH)

2021 Research Highlights — Human Health Advances | National Institutes of Health (NIH)

Side Effects in Older Adults | Blocking Immune Cells | Medulloblastoma, Cancer Information Highlights, 12/22/2021

Side Effects in Older Adults | Blocking Immune Cells | Medulloblastoma, Cancer Information Highlights, 12/22/2021

Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19 | FDA

Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19 | FDA

FDA approves add-on therapy to lower cholesterol among certain high-risk adults | FDA

FDA approves add-on therapy to lower cholesterol among certain high-risk adults | FDA

Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults | FDA

Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults | FDA

50th Anniversary of the National Cancer Act: It’s Time to End Cancer as ...

European Mistletoe | NCCIH

European Mistletoe | NCCIH

miércoles, 22 de diciembre de 2021

Convalescent Plasma Cuts COVID-19 Hospitalizations in Half: Study

Convalescent Plasma Cuts COVID-19 Hospitalizations in Half: Study

Bamlanivimab's Effects in COVID-19 Depend on Antibodies

Bamlanivimab's Effects in COVID-19 Depend on Antibodies

Skip the sleep lab and go wireless at home - ISRAEL21c

Skip the sleep lab and go wireless at home - ISRAEL21c

Israel prepares for fourth vaccination round - ISRAEL21c

Israel prepares for fourth vaccination round - ISRAEL21c

When a waiting room becomes a chance to empower chronically ill kids - ISRAEL21c

When a waiting room becomes a chance to empower chronically ill kids - ISRAEL21c

This startup aims to cure the US care access crisis - ISRAEL21c

This startup aims to cure the US care access crisis - ISRAEL21c

New Links on MedlinePlus

New Links on MedlinePlus

The Lancet Commission on the future of care and clinical research in autism

The Lancet Commission on the future of care and clinical research in autism

The Lancet Commission on the future of care and clinical research in autism - The Lancet

The Lancet Commission on the future of care and clinical research in autism - The Lancet

Statement—NIH Celebrates FDA Approval of Long-Acting Injectable Drug for HIV Prevention | NIH: National Institute of Allergy and Infectious Diseases

Statement—NIH Celebrates FDA Approval of Long-Acting Injectable Drug for HIV Prevention | NIH: National Institute of Allergy and Infectious Diseases

System-Wide Changes Can Help Reduce Cancer Disparities - National Cancer Institute

System-Wide Changes Can Help Reduce Cancer Disparities - National Cancer Institute

December 2021 CC News

December 2021 CC News

FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention | HIV.gov

FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention | HIV.gov

Parenting program to prevent obesity in firstborn children benefits siblings | National Institutes of Health (NIH)

Parenting program to prevent obesity in firstborn children benefits siblings | National Institutes of Health (NIH)

NIH celebrates FDA approval of long-acting injectable drug for HIV prevention | National Institutes of Health (NIH)

NIH celebrates FDA approval of long-acting injectable drug for HIV prevention | National Institutes of Health (NIH)

Mindfulness as a Support for Healing Conversations and Actions Toward Social Justice and Equity | NCCIH

Mindfulness as a Support for Healing Conversations and Actions Toward Social Justice and Equity | NCCIH

Omicron tracker: AstraZeneca works on specific vaccine; WHO says variant in 106 countries | Explained News,The Indian Express

Omicron tracker: AstraZeneca works on specific vaccine; WHO says variant in 106 countries | Explained News,The Indian Express

martes, 21 de diciembre de 2021

Clinical trial shows preliminary efficacy of all-oral regimen for patients with lenalidomide-refractory multiple myeloma

Clinical trial shows preliminary efficacy of all-oral regimen for patients with lenalidomide-refractory multiple myeloma

Younger cancer patients at particularly increased risk of mortality from COVID-19

Younger cancer patients at particularly increased risk of mortality from COVID-19

People with multimorbidity more likely to have chronic pain

People with multimorbidity more likely to have chronic pain

Understanding SARS-CoV-2-induced systemic amyloidosis

Understanding SARS-CoV-2-induced systemic amyloidosis

Insight into COVID-19 brain complications

Insight into COVID-19 brain complications

AHA Supports CDC Preference for mRNA COVID-19 Vaccines

AHA Supports CDC Preference for mRNA COVID-19 Vaccines

COVID-19 Booster Causes Axilla Swelling

COVID-19 Booster Causes Axilla Swelling

In COVID, New-Onset Seizures More Common Than Breakthrough Seizures

In COVID, New-Onset Seizures More Common Than Breakthrough Seizures

Diabetes Care 2022: Screen More, Personalize, Use Technology

Diabetes Care 2022: Screen More, Personalize, Use Technology

Visceral Fat May Help ID Heart Risk in Obese Youth

Visceral Fat May Help ID Heart Risk in Obese Youth

Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Ovarian Germ Cell Tumors Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Ovarian Germ Cell Tumors Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Genetics of Skin Cancer (PDQ®)–Health Professional Version - National Cancer Institute

Genetics of Skin Cancer (PDQ®)–Health Professional Version - National Cancer Institute

Curcumin (Curcuma, Turmeric) and Cancer (PDQ®)–Health Professional Version - National Cancer Institute

Curcumin (Curcuma, Turmeric) and Cancer (PDQ®)–Health Professional Version - National Cancer Institute

Cannabis and Cannabinoids (PDQ®)–Health Professional Version - National Cancer Institute

Cannabis and Cannabinoids (PDQ®)–Health Professional Version - National Cancer Institute

FDA approves maintenance treatment for severe asthma | FDA

FDA approves maintenance treatment for severe asthma | FDA

FDA Approves Second Biosimilar Insulin Product, Rezvoglar (insulin glargine-aglr)

label

NIH Scientists Urge Pursuit of Universal Coronavirus Vaccine | NIH: National Institute of Allergy and Infectious Diseases

NIH Scientists Urge Pursuit of Universal Coronavirus Vaccine | NIH: National Institute of Allergy and Infectious Diseases

FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention | FDA

FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention | FDA

FDA approves drug to treat, help prevent types of blood clots in certain pediatric populations | FDA

FDA approves drug to treat, help prevent types of blood clots in certain pediatric populations | FDA

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients | NEJM

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients | NEJM

Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show | The BMJ

Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show | The BMJ

WHO recommends against the use of convalescent plasma to treat COVID-19

WHO recommends against the use of convalescent plasma to treat COVID-19

Fauci: Omicron-specific version of Covid vaccines may not be necessary

Fauci: Omicron-specific version of Covid vaccines may not be necessary

Covid-19: Do vaccines work against omicron—and other questions answered | The BMJ

Covid-19: Do vaccines work against omicron—and other questions answered | The BMJ

COVID-19 Update: Omicron Variant

lunes, 20 de diciembre de 2021

A test to identify antibody effectiveness against COVID-19 variants

A test to identify antibody effectiveness against COVID-19 variants

Updates to Guidance on Prevention and Management of VTE

Updates to Guidance on Prevention and Management of VTE

Dec 17 2021 This Week in Cardiology

Dec 17 2021 This Week in Cardiology

Anifrolumab (Saphnelo) Gets Green Light for Approval in EU

Anifrolumab (Saphnelo) Gets Green Light for Approval in EU

Kidney Fat Thickness Predicts Metabolic Syndrome in Diabetes

Kidney Fat Thickness Predicts Metabolic Syndrome in Diabetes

Diet That Mimics Periodic Fasting Slows Diabetic Kidney Disease

Diet That Mimics Periodic Fasting Slows Diabetic Kidney Disease

Suspect Cannabis With Diabetic Ketoacidosis and High pH

Suspect Cannabis With Diabetic Ketoacidosis and High pH

The Challenge, Promise of Getting Oral COVID Drugs Into Practice

The Challenge, Promise of Getting Oral COVID Drugs Into Practice

Aggressive Supportive Treatment for COVID-19 in Leukemia and MDS

Aggressive Supportive Treatment for COVID-19 in Leukemia and MDS

The drugs to fight Covid-19 are already on the market - ISRAEL21c

The drugs to fight Covid-19 are already on the market - ISRAEL21c

Blue-green Spirulina algae may prevent serious Covid-19 - ISRAEL21c

Blue-green Spirulina algae may prevent serious Covid-19 - ISRAEL21c

What we know about Omicron and how to avoid getting it - ISRAEL21c

What we know about Omicron and how to avoid getting it - ISRAEL21c

What the world can learn about immunity from Israel’s vaccine rollout - ISRAEL21c

What the world can learn about immunity from Israel’s vaccine rollout - ISRAEL21c

Covid and Pfizer: What has Israel discovered so far? - ISRAEL21c

Covid and Pfizer: What has Israel discovered so far? - ISRAEL21c

Has Israel just found the cure for Covid? - ISRAEL21c

Has Israel just found the cure for Covid? - ISRAEL21c

Skin cancer diagnosis is about to undergo a revolution - ISRAEL21c

Skin cancer diagnosis is about to undergo a revolution - ISRAEL21c

A diagnostic tool that treats autism like cancer - ISRAEL21c

A diagnostic tool that treats autism like cancer - ISRAEL21c

FDA Approves New Treatment for Myasthenia Gravis | FDA

FDA Approves New Treatment for Myasthenia Gravis | FDA

domingo, 19 de diciembre de 2021

Specific PHGKB|Reproductive and Child Health PHGKB|PHGKB

Specific PHGKB|Reproductive and Child Health PHGKB|PHGKB

Specific PHGKB|Rare Diseases PHGKB|PHGKB

Specific PHGKB|Rare Diseases PHGKB|PHGKB

Family Health History | CDC

Family Health History | CDC

Omicron Variant: What You Need to Know | CDC

Omicron Variant: What You Need to Know | CDC

Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England - The Lancet Regional Health – Europe

Risk of venous thrombotic events and thrombocytopenia in sequential time periods after ChAdOx1 and BNT162b2 COVID-19 vaccines: A national cohort study in England - The Lancet Regional Health – Europe

Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological study - The Lancet Regional Health – Europe

Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological study - The Lancet Regional Health – Europe

Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study - EClinicalMedicine

Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study - EClinicalMedicine

Rehabilitation needs following COVID-19: Five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms - EClinicalMedicine

Rehabilitation needs following COVID-19: Five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms - EClinicalMedicine

A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India - EClinicalMedicine

A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India - EClinicalMedicine

Disentangling post-vaccination symptoms from early COVID-19 - EClinicalMedicine

Disentangling post-vaccination symptoms from early COVID-19 - EClinicalMedicine

Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study - EClinicalMedicine

Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study - EClinicalMedicine

Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex - EBioMedicine

Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex - EBioMedicine

Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries - The Lancet Rheumatology

Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries - The Lancet Rheumatology

Extracorporeal haemoadsorption: does the evidence support its routine use in critical care? - The Lancet Respiratory Medicine

Extracorporeal haemoadsorption: does the evidence support its routine use in critical care? - The Lancet Respiratory Medicine

Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial - The Lancet Respiratory Medicine

Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial - The Lancet Respiratory Medicine

The effect of mandatory COVID-19 certificates on vaccine uptake: synthetic-control modelling of six countries - The Lancet Public Health

The effect of mandatory COVID-19 certificates on vaccine uptake: synthetic-control modelling of six countries - The Lancet Public Health

The hidden burden of eating disorders during the COVID-19 pandemic - The Lancet Psychiatry

The hidden burden of eating disorders during the COVID-19 pandemic - The Lancet Psychiatry

Emerging SARS-CoV-2 variants: shooting the messenger - The Lancet Infectious Diseases

Emerging SARS-CoV-2 variants: shooting the messenger - The Lancet Infectious Diseases

Anticoagulation in COVID-19 - The Lancet

Anticoagulation in COVID-19 - The Lancet

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial - The Lancet

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial - The Lancet

COVID-19: where do we go from here? - The Lancet

COVID-19: where do we go from here? - The Lancet

sábado, 18 de diciembre de 2021

Brain death to be reviewed. It could undermine the health care system confidence

Brain death to be reviewed. It could undermine the health care system confidence

Conscientious objection when requested is a personal right

Conscientious objection when requested is a personal right

Medical data erased. Transgenders' “right to be forgotten” in personal data protection regulation

Medical data erased. Transgenders' “right to be forgotten” in personal data protection regulation

SARS-CoV-2 leak gains traction the virus has a lot to say

SARS-CoV-2 leak gains traction the virus has a lot to say

Omicron blindspots: why it’s hard to track coronavirus variants

Omicron blindspots: why it’s hard to track coronavirus variants

How severe are Omicron infections?

How severe are Omicron infections?

Stretchy electronics go wireless for flexible wearables

Stretchy electronics go wireless for flexible wearables

How COVID vaccines shaped 2021 in eight powerful charts

How COVID vaccines shaped 2021 in eight powerful charts

Decision makers need constantly updated evidence synthesis

Decision makers need constantly updated evidence synthesis

Capturing the Extracellular Matrix in 3D Color – NIH Director's Blog

Capturing the Extracellular Matrix in 3D Color – NIH Director's Blog

NIH scientists urge pursuit of universal coronavirus vaccine | National Institutes of Health (NIH)

NIH scientists urge pursuit of universal coronavirus vaccine | National Institutes of Health (NIH)

COVID-19: WHO advises against convalescent plasma

COVID-19: WHO advises against convalescent plasma

Co-administration of influenza and COVID-19 vaccines

Co-administration of influenza and COVID-19 vaccines

COVID-19 Around the world weekly highlights: mandatory face mask, vaccination for children, and booster doses…

COVID-19 Around the world weekly highlights: mandatory face mask, vaccination for children, and booster doses…

COVID-19 vaccine and autoimmune disease flare

COVID-19 vaccine and autoimmune disease flare

COVID-19: natural infection as protection against reinfection

COVID-19: natural infection as protection against reinfection

Statins: MedlinePlus

Statins: MedlinePlus

Prostate-Specific Antigen (PSA) Test: MedlinePlus Medical Test

Prostate-Specific Antigen (PSA) Test: MedlinePlus Medical Test

Stress: MedlinePlus

Stress: MedlinePlus

Immunotherapy Combination for BRAF+ Melanoma - National Cancer Institute

Immunotherapy Combination for BRAF+ Melanoma - National Cancer Institute

New Links on MedlinePlus

New Links on MedlinePlus

FDA approves drug to treat sickle cell disease in patients aged 4 up to 11 years | FDA

FDA approves drug to treat sickle cell disease in patients aged 4 up to 11 years | FDA

Improving Dose Selection In Children through Better Estimates of Renal Function | FDA

Improving Dose Selection In Children through Better Estimates of Renal Function | FDA

viernes, 17 de diciembre de 2021

The HIV Life Cycle | NIH

The HIV Life Cycle | NIH

HIV and AIDS: The Basics | NIH

HIV and AIDS: The Basics | NIH

Geriatric Assessment Reduces Cancer Treatment Side Effects - National Cancer Institute

Geriatric Assessment Reduces Cancer Treatment Side Effects - National Cancer Institute

Vitamins and Minerals | NCCIH

Vitamins and Minerals | NCCIH

Polyphenol-rich diet improves the intestinal permeability in older adults

Polyphenol-rich diet improves the intestinal permeability in older adults

Analysis of the alteration of neutralizing titers with Omicron pseudovirus

Analysis of the alteration of neutralizing titers with Omicron pseudovirus

Long-term characteristics of long-COVID following hospitalization

Long-term characteristics of long-COVID following hospitalization

Impact of SARS-CoV-2 Omicron mutations on the use of therapeutic antibodies in COVID-19 treatment

Impact of SARS-CoV-2 Omicron mutations on the use of therapeutic antibodies in COVID-19 treatment

Identifying protein targets in SARS-CoV-2 via machine learning

Identifying protein targets in SARS-CoV-2 via machine learning

Primary responses to SARS-CoV-2 in COVID-19 naïve vaccinees

Primary responses to SARS-CoV-2 in COVID-19 naïve vaccinees

Effectiveness of COVID-19 vaccines among older male veterans

Effectiveness of COVID-19 vaccines among older male veterans

NIMH » Understanding the Characteristics of Suicide in Young Children

NIMH » Understanding the Characteristics of Suicide in Young Children

5 Questions with FIVE QUESTIONS person name | NIAAA Spectrum | NIAAA Spectrum

5 Questions with FIVE QUESTIONS person name | NIAAA Spectrum | NIAAA Spectrum

Medical Device Cybersecurity: What You Need to Know | FDA

Medical Device Cybersecurity: What You Need to Know | FDA

Weight Loss, Male Enhancement and Other Products Sold Online or in Stores May Be Dangerous | FDA

Weight Loss, Male Enhancement and Other Products Sold Online or in Stores May Be Dangerous | FDA

Know Your Treatment Options for COVID-19 | FDA

Know Your Treatment Options for COVID-19 | FDA

Why You Should Not Use Ivermectin to Treat or Prevent COVID-19 | FDA

Why You Should Not Use Ivermectin to Treat or Prevent COVID-19 | FDA

List of the latest marketing authorisations and orphan medicinal products designations | www.eurordis.org

List of the latest marketing authorisations and orphan medicinal products designations | www.eurordis.org

General discussion: Updates

General discussion: Updates Are you looking to connect with others around the world who are living with the same ultra-rare disease? Check out the RareConnect general discussion community now where people are waiting to connect!!

SMA Screen at birth Save Lives

Repurposing of authorised medicines: pilot to support not-for-profit organisations and academia | European Medicines Agency

Repurposing of authorised medicines: pilot to support not-for-profit organisations and academia | European Medicines Agency

Attending the #EURORDISBlackPearlAwards on Rare Disease

Attending the #EURORDISBlackPearlAwards on Rare Disease

Fee-waivers - ECRD2022 - EUROPEAN CONFERENCE ON RARE DISEASES & ORPHAN PRODUCTS

Fee-waivers - ECRD2022

Rare Disease Day 2022 – Raising awareness for patients, families and carers around the world that are affected by rare diseases.

Rare Disease Day 2022 – Raising awareness for patients, families and carers around the world that are affected by rare diseases.

Rare Adult Cancers Included in the Final Report of the European Parliament’s Special Committee on Beating Cancer - EURORDIS - The Voice of Rare Disease Patients in Europe

EURORDIS - The Voice of Rare Disease Patients in Europe

UN Resolution on Persons Living with a Rare Disease - Rare Diseases International

UN Resolution on Persons Living with a Rare Disease - Rare Diseases International

EURORDIS - The Voice of Rare Disease Patients in Europe: UN Resolution is adopted: what does it mean for Europe?

EURORDIS - The Voice of Rare Disease Patients in Europe

jueves, 16 de diciembre de 2021

Symptoms after a third mRNA vaccine among patients with inflammatory bowel disease

Symptoms after a third mRNA vaccine among patients with inflammatory bowel disease

Gene key to excessive cell proliferation could be a potential target for fatal pulmonary hypertension

Gene key to excessive cell proliferation could be a potential target for fatal pulmonary hypertension

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

Using fungal vaccine to train stem cells and enhance immune response to infections

Using fungal vaccine to train stem cells and enhance immune response to infections

Which population does extreme heat affect the most?

Which population does extreme heat affect the most?

Epilepsy Patients Much More Likely to Die of COVID

Epilepsy Patients Much More Likely to Die of COVID

COVID Vax Leads Rheumatology Patients to Modify Drug Regimens

COVID Vax Leads Rheumatology Patients to Modify Drug Regimens

A Pandemic Silver Lining? Dramatic Drop in Teen Drug Use

A Pandemic Silver Lining? Dramatic Drop in Teen Drug Use

Newer Migraine Meds 'Here to Stay,' but Are They More Effective?

Newer Migraine Meds 'Here to Stay,' but Are They More Effective?

Fauci: Boosters Work Against Omicron

Fauci: Boosters Work Against Omicron

Microbiome to blame for weight gain after you quit smoking - ISRAEL21c

Microbiome to blame for weight gain after you quit smoking - ISRAEL21c

How Israelis help the world fight mosquito-borne diseases - ISRAEL21c

How Israelis help the world fight mosquito-borne diseases - ISRAEL21c

Pfizer booster cuts Covid deaths 90% in people over 50 - ISRAEL21c

Pfizer booster cuts Covid deaths 90% in people over 50 - ISRAEL21c

What we know about Omicron and how to avoid getting it - ISRAEL21c

What we know about Omicron and how to avoid getting it - ISRAEL21c

2 Pfizer doses can’t fight Omicron, but booster helps - ISRAEL21c

2 Pfizer doses can’t fight Omicron, but booster helps - ISRAEL21c

Experimental mRNA HIV Vaccine Safe, Shows Promise in Animals | HIV.gov

Experimental mRNA HIV Vaccine Safe, Shows Promise in Animals | HIV.gov

Determining the Minimally Effective Dose of a Clinical Candidate Adeno-Associated Virus Vector in a Mouse Model of Hemophilia A | Human Gene Therapy

Determining the Minimally Effective Dose of a Clinical Candidate Adeno-Associated Virus Vector in a Mouse Model of Hemophilia A | Human Gene Therapy

Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals | FDA

Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals | FDA

NIH study suggests women with disabilities have higher risk of birth complications and death | National Institutes of Health (NIH)

NIH study suggests women with disabilities have higher risk of birth complications and death | National Institutes of Health (NIH)

New Links on MedlinePlus

New Links on MedlinePlus

FDA Approves First Drug to Prevent Graft Versus Host Disease | FDA

FDA Approves First Drug to Prevent Graft Versus Host Disease | FDA

Low-Back Pain and Complementary Health Approaches

Low-Back Pain and Complementary Health Approaches

FDA approves first drug to decrease urine protein in IgA nephropathy, a rare kidney disease | FDA

FDA approves first drug to decrease urine protein in IgA nephropathy, a rare kidney disease | FDA

Omicron infects 70 times faster but may cause less severe disease: Study | World News,The Indian Express

Omicron infects 70 times faster but may cause less severe disease: Study | World News,The Indian Express

miércoles, 15 de diciembre de 2021

Orphanet Journal of Rare Diseases | Home page

Orphanet Journal of Rare Diseases | Home page

Fixing the US Maternal Health Problem: Signs of Hope?

Fixing the US Maternal Health Problem: Signs of Hope?

Unrestricted Prescribing of Mifepristone Is Safe, Study Shows

Unrestricted Prescribing of Mifepristone Is Safe, Study Shows

Children and COVID: Weekly Cases Resume Their Climb

Children and COVID: Weekly Cases Resume Their Climb

COVID-19 Asymptomatic Infection Rate Remains High

COVID-19 Asymptomatic Infection Rate Remains High

Advancing blood research to help patients recover from COVID-19 | NHLBI, NIH

Advancing blood research to help patients recover from COVID-19 | NHLBI, NIH

Unraveling the Mysteries of COVID-19 | NHLBI, NIH

Unraveling the Mysteries of COVID-19 | NHLBI, NIH

National Institutes of Health Sleep Research Plan | NHLBI, NIH

National Institutes of Health Sleep Research Plan | NHLBI, NIH

2021 Year in Review | NIDDK

2021 Year in Review | NIDDK

Percentage of adolescents reporting drug use decreased significantly in 2021 as the COVID-19 pandemic endured | National Institutes of Health (NIH)

Percentage of adolescents reporting drug use decreased significantly in 2021 as the COVID-19 pandemic endured | National Institutes of Health (NIH)

NIH researchers identify potential AMD drugs with stem-cell based research tool | National Institutes of Health (NIH)

NIH researchers identify potential AMD drugs with stem-cell based research tool | National Institutes of Health (NIH)

School-Based Suicide Prevention Registration, Fri, Jan 14, 2022 at 2:00 PM | Eventbrite

School-Based Suicide Prevention Registration, Fri, Jan 14, 2022 at 2:00 PM | Eventbrite

Understanding novel cancer therapies that help improve survival rates

LinkedIn

T-cell therapy with nivolumab safe for Hodgkin's lymphoma - Children's National

T-cell therapy with nivolumab safe for Hodgkin's lymphoma - Children's National

Study with largest cohort in the Western world sheds light on Epstein-Barr virus - Children's National

Study with largest cohort in the Western world sheds light on Epstein-Barr virus - Children's National

Personalized T cell immunotherapy for brain tumors closer to becoming reality - Children's National

Personalized T cell immunotherapy for brain tumors closer to becoming reality - Children's National

New Links on MedlinePlus

New Links on MedlinePlus

Antiviral drug shows promise against COVID-19 and RSV | National Institutes of Health (NIH)

Antiviral drug shows promise against COVID-19 and RSV | National Institutes of Health (NIH)

Viagra associated with reduced risk of Alzheimer’s disease | National Institutes of Health (NIH)

Viagra associated with reduced risk of Alzheimer’s disease | National Institutes of Health (NIH)

Daytime meals may reduce health risks of night shift work | National Institutes of Health (NIH)

Daytime meals may reduce health risks of night shift work | National Institutes of Health (NIH)

Suicidal tendencies linked to specific genes, correlated with other psychiatric risk factors such as smoking and sleep disturbances - Genetic Literacy Project

Suicidal tendencies linked to specific genes, correlated with other psychiatric risk factors such as smoking and sleep disturbances - Genetic Literacy Project

martes, 14 de diciembre de 2021

BMC Cancer | Home page

BMC Cancer | Home page

Biology of Sex Differences | Home page

Biology of Sex Differences | Home page

Acta Neuropathologica Communications | Home page

Acta Neuropathologica Communications | Home page

NIH-funded study could help improve deep brain stimulation therapy for OCD | National Institutes of Health (NIH)

NIH-funded study could help improve deep brain stimulation therapy for OCD | National Institutes of Health (NIH)

SARS-CoV-2 patients exhibit high specialized pro-resolving molecule serum levels

SARS-CoV-2 patients exhibit high specialized pro-resolving molecule serum levels

New guidelines for heart-healthy eating

New guidelines for heart-healthy eating

What Are the Different Types of Dementia? | National Institute on Aging

What Are the Different Types of Dementia? | National Institute on Aging

Latest on Omicron Variant and COVID-19 Vaccine Protection – NIH Director's Blog

Latest on Omicron Variant and COVID-19 Vaccine Protection – NIH Director's Blog

Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ®)–Health Professional Version - National Cancer Institute

Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ®)–Health Professional Version - National Cancer Institute

Essiac/Flor Essence (PDQ®)–Health Professional Version - National Cancer Institute

Essiac/Flor Essence (PDQ®)–Health Professional Version - National Cancer Institute

Beyond Omicron: what’s next for COVID’s viral evolution

Beyond Omicron: what’s next for COVID’s viral evolution

COVID-19 Update: Omicron Variant

Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network

Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network

Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11 | European Medicines Agency

Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11 | European Medicines Agency

First, small study suggests Omicron is a larger threat to Covid-19 immunity

First, small study suggests Omicron is a larger threat to Covid-19 immunity

Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia - The Lancet Respiratory Medicine

Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia - The Lancet Respiratory Medicine

Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults | Circulation

Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults | Circulation

BNT162b2 Vaccine Booster and Mortality Due to Covid-19 | NEJM

BNT162b2 Vaccine Booster and Mortality Due to Covid-19 | NEJM

Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network

Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network

Pfizer confirms Covid-19 pill’s results, potency versus omicron | World News,The Indian Express

Pfizer confirms Covid-19 pill’s results, potency versus omicron | World News,The Indian Express

lunes, 13 de diciembre de 2021

Theta Burst Brain Stimulation To Improve Memory in Older Adults With Mild Cognitive Impairment

Theta Burst Brain Stimulation To Improve Memory in Older Adults With Mild Cognitive Impairment

New Links on MedlinePlus

New Links on MedlinePlus

The race to make vaccines for a dangerous respiratory virus

The race to make vaccines for a dangerous respiratory virus

Merck’s COVID pill loses its lustre: what that means for the pandemic

Merck’s COVID pill loses its lustre: what that means for the pandemic

The Human Proteoform Project: Defining the human proteome

The Human Proteoform Project: Defining the human proteome

'Remarkable' Results With CAR T Cells Could Make Chemo Obsolete

'Remarkable' Results With CAR T Cells Could Make Chemo Obsolete

Major COVID-19 Case Growth Expected in Coming Weeks

Major COVID-19 Case Growth Expected in Coming Weeks

How Does Atopic Dermatitis Present in Skin of Color?

How Does Atopic Dermatitis Present in Skin of Color?

CDC: Boosters Key in Protecting Against Omicron

CDC: Boosters Key in Protecting Against Omicron

Stem Cell Transplant to Generate Testosterone for Hypogonadism?

Stem Cell Transplant to Generate Testosterone for Hypogonadism?

Nothing Will Stop Us

New Links on MedlinePlus

New Links on MedlinePlus

Children's National to study long-term effects of COVID- Children's National

Children's National to study long-term effects of COVID- Children's National

An assessment of orthopedic surgery residency program websites - Children's National

An assessment of orthopedic surgery residency program websites - Children's National

Increasing the patient’s voice in osteogenesis imperfecta research and care - Children's National

Increasing the patient’s voice in osteogenesis imperfecta research and care - Children's National

COVID-19 Single-Dose Nasal Vaccine Designed for Infants, Children | NIH: National Institute of Allergy and Infectious Diseases

COVID-19 Single-Dose Nasal Vaccine Designed for Infants, Children | NIH: National Institute of Allergy and Infectious Diseases

NIH-funded study could help improve deep brain stimulation therapy for OCD | National Institutes of Health (NIH)

NIH-funded study could help improve deep brain stimulation therapy for OCD | National Institutes of Health (NIH)

The Lancet Child & Adolescent Health

The Lancet Child & Adolescent Health

Pembrolizumab to Prevent Early-Stage Melanoma Recurrence - National Cancer Institute

Pembrolizumab to Prevent Early-Stage Melanoma Recurrence - National Cancer Institute

Tumors Shed Protein to Create Barriers Blocking Immune Cells - National Cancer Institute

Tumors Shed Protein to Create Barriers Blocking Immune Cells - National Cancer Institute

Researchers develop a universal SARS-CoV-2 neutralizing antibody

Researchers develop a universal SARS-CoV-2 neutralizing antibody

COVID-19 in association with pre-existing mental and physical health issues

COVID-19 in association with pre-existing mental and physical health issues

New research identifies the cause of Alzheimer’s progression

New research identifies the cause of Alzheimer’s progression

Seasonal coronaviruses may help estimate SARS-CoV-2 reinfection risk

Seasonal coronaviruses may help estimate SARS-CoV-2 reinfection risk

Sarcopenia and COVID-19

Sarcopenia and COVID-19

Study suggests pre-existing human common cold coronavirus antibodies hinder SARS-CoV-2 immunity

Study suggests pre-existing human common cold coronavirus antibodies hinder SARS-CoV-2 immunity

Workshop on Psychedelics as Therapeutics: Gaps, Challenges & Opportunities Tickets, Wed, Jan 12, 2022 at 9:00 AM | Eventbrite

Workshop on Psychedelics as Therapeutics: Gaps, Challenges & Opportunities Tickets, Wed, Jan 12, 2022 at 9:00 AM | Eventbrite

Omicron variant leads to generally mild symptoms in 40+ known US cases - Genetic Literacy Project

Omicron variant leads to generally mild symptoms in 40+ known US cases - Genetic Literacy Project

If given, Covid-19 booster must be different vaccine: view in top expert body

If given, Covid-19 booster must be different vaccine: view in top expert body

domingo, 12 de diciembre de 2021

Main|Amyotrophic lateral sclerosis|PHGKB

Main|Search|PHGKB

mRNA vaccines offer hope for HIV L Morris, Nature Medicine, December 9, 2021

Main|Search|PHGKB

A Phenome Wide Association Study of Severe COVID-19 Genetic Risk Variants JA Regan et al, MEDRXIV, December 11, 2021

Main|Search|PHGKB

The power of genetic diversity in genome-wide association studies of lipids SE Graham et al, Nature, December 9, 2021

Main|Search|PHGKB

Main|Liquid biopsy|PHGKB

Main|Search|PHGKB

Main|Alzheimer's disease|PHGKB

Main|Search|PHGKB

CDC-Authored Publications Update|PHGKB

CDC-Authored Publications Update|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

Main|Cascade screening or cascade testing|PHGKB

Main|Search|PHGKB

The Use of Machine Learning in Health Care: No Shortcuts on the Long Road to Evidence-based Precision Health | Blogs | CDC

The Use of Machine Learning in Health Care: No Shortcuts on the Long Road to Evidence-based Precision Health | Blogs | CDC

COVID-19 GPH|Home|PHGKB

COVID-19 GPH|Home|PHGKB

Omicron Variant: What You Need to Know | CDC

Omicron Variant: What You Need to Know | CDC

sábado, 11 de diciembre de 2021

What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients? - EBioMedicine

What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients? - EBioMedicine

Narrating the natural history of live infection by SARS CoV-2 VOC in animal models - EBioMedicine

Narrating the natural history of live infection by SARS CoV-2 VOC in animal models - EBioMedicine

A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2 - EBioMedicine

A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2 - EBioMedicine

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial - EBioMedicine

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial - EBioMedicine

Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2 - EBioMedicine

Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2 - EBioMedicine

Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination - The Lancet Rheumatology

Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination - The Lancet Rheumatology

Mental health before and during the pandemic in people with systemic sclerosis - The Lancet Rheumatology

Mental health before and during the pandemic in people with systemic sclerosis - The Lancet Rheumatology

Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease - The Lancet Rheumatology

Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease - The Lancet Rheumatology

Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study - The Lancet Rheumatology

Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study - The Lancet Rheumatology

Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19 - The Lancet Respiratory Medicine

Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19 - The Lancet Respiratory Medicine

Combining active ingredients to treat depression in the wake of COVID-19 - The Lancet Psychiatry

Combining active ingredients to treat depression in the wake of COVID-19 - The Lancet Psychiatry

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era - The Lancet Microbe

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era - The Lancet Microbe

WHO international standard for SARS-CoV-2 antibodies to determine markers of protection - The Lancet Microbe

WHO international standard for SARS-CoV-2 antibodies to determine markers of protection - The Lancet Microbe

Serial antigen rapid testing in staff of a large acute hospital - The Lancet Infectious Diseases

Serial antigen rapid testing in staff of a large acute hospital - The Lancet Infectious Diseases

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom - The Lancet Infectious Diseases

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom - The Lancet Infectious Diseases

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials - The Lancet Infectious Diseases

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials - The Lancet Infectious Diseases

COVID-19 antivirals must not affect HIV drug supply - The Lancet HIV

COVID-19 antivirals must not affect HIV drug supply - The Lancet HIV

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial - The Lancet

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial - The Lancet

Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19 - The Lancet

Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19 - The Lancet

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial - The Lancet

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial - The Lancet

viernes, 10 de diciembre de 2021

CDC, FDA Sign Off on Pfizer Boosters for 16- and 17-Year-Olds

CDC, FDA Sign Off on Pfizer Boosters for 16- and 17-Year-Olds

ECDC warns COVID-19 restrictions must be urgently applied

ECDC warns COVID-19 restrictions must be urgently applied

Neurological sequelae after COVID-19 and COVID-19 vaccines

Neurological sequelae after COVID-19 and COVID-19 vaccines

COVID-19 vaccine and autoimmune disease flare

COVID-19 vaccine and autoimmune disease flare

COVID-19 Around the world weekly highlights: Omicron variant, new lockdown, and flight restrictions…

COVID-19 Around the world weekly highlights: Omicron variant, new lockdown, and flight restrictions…

COVID-19: IDSA rapid guidelines highlight "appropriate" PPE for health care personnel

COVID-19: IDSA rapid guidelines highlight "appropriate" PPE for health care personnel

Experimental mRNA HIV vaccine safe, shows promise in animals | National Institutes of Health (NIH)

Experimental mRNA HIV vaccine safe, shows promise in animals | National Institutes of Health (NIH)

New Links on MedlinePlus

New Links on MedlinePlus

Drug allergies: MedlinePlus Medical Encyclopedia

Drug allergies: MedlinePlus Medical Encyclopedia

Biotin: MedlinePlus Supplements

Biotin: MedlinePlus Supplements

Headache | MedlinePlus

Headache | MedlinePlus

Things To Know About Dietary Supplements for Children

Things To Know About Dietary Supplements for Children

No animals harmed in new chip drug tests that are faster and cheaper - ISRAEL21c

No animals harmed in new chip drug tests that are faster and cheaper - ISRAEL21c

A smart polymer that would heal wounds without sutures - ISRAEL21c

A smart polymer that would heal wounds without sutures - ISRAEL21c

What we know about Omicron and how to avoid getting it - ISRAEL21c

What we know about Omicron and how to avoid getting it - ISRAEL21c

Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16- and 17-Year-Olds | FDA

Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16- and 17-Year-Olds | FDA

NIH MedlinePlus Magazine

NIH MedlinePlus Magazine

Experimental mRNA HIV Vaccine Safe, Shows Promise in Animals | NIH: National Institute of Allergy and Infectious Diseases

Experimental mRNA HIV Vaccine Safe, Shows Promise in Animals | NIH: National Institute of Allergy and Infectious Diseases

Dermal Filler Do's and Don'ts for Wrinkles, Lips and More | FDA

Dermal Filler Do's and Don'ts for Wrinkles, Lips and More | FDA

Dietary Supplements | HIV/AIDS Research | COVID-19 Booster | Mental Health Conversations | Healthy Weight

Dietary Supplements | HIV/AIDS Research | COVID-19 Booster | Mental Health Conversations | Healthy Weight

How Consumers Can Report an Adverse Event or Serious Problem to FDA | FDA

How Consumers Can Report an Adverse Event or Serious Problem to FDA | FDA

Pregnant? Breastfeeding? FDA Aims to Improve Drug Information | FDA

Pregnant? Breastfeeding? FDA Aims to Improve Drug Information | FDA

FDA Proposes Changes to Food Safety Modernization Act Rule to Enhance Safety of Agricultural Water Used on Produce | FDA

FDA Proposes Changes to Food Safety Modernization Act Rule to Enhance Safety of Agricultural Water Used on Produce | FDA

FDA Pharmacists Help You Use Medicines Safely | FDA

FDA Pharmacists Help You Use Medicines Safely | FDA

FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns | FDA

FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns | FDA

Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals | FDA

Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals | FDA